167 related articles for article (PubMed ID: 38409363)
1. Exploring prognostic factors and treatment strategies for long-term survival in pleomorphic xanthoastrocytoma patients.
Lee C; Byeon Y; Kim GJ; Jeon J; Hong CK; Kim JH; Kim YH; Cho YH; Hong SH; Chong SJ; Song SW
Sci Rep; 2024 Feb; 14(1):4615. PubMed ID: 38409363
[TBL] [Abstract][Full Text] [Related]
2. Impact of Grade on Survival in Pleomorphic Xanthoastrocytoma and Low Prevalence of BRAF V600E Mutation.
Gandham EJ; Goyal-Honavar A; Beno D; Pai R; Balakrishan R; Jasper A; Gowri M; Moorthy RK; Chacko AG; Chacko G
World Neurosurg; 2022 Aug; 164():e922-e928. PubMed ID: 35618235
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Pleomorphic Xanthoastrocytoma: A National Database Inquiry on Current Treatment Approaches in the United States.
Scarpelli DB; Yu Y; Tep AC; Bergue B; Degnin C; Chen Y; McClelland S; Jaboin JJ
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1415. PubMed ID: 33963808
[TBL] [Abstract][Full Text] [Related]
4. MRI characteristics predict BRAF V600E status in gangliogliomas and pleomorphic xanthoastrocytomas and provide survival prognostication.
Jiang B; Zheng Y; She D; Xing Z; Cao D
Acta Radiol; 2024 Jan; 65(1):33-40. PubMed ID: 37401109
[TBL] [Abstract][Full Text] [Related]
5. Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study Group.
Ono T; Sasajima T; Shimizu H; Natsumeda M; Kanamori M; Asano K; Beppu T; Matsuda K; Ichikawa M; Fujii Y; Ohkuma H; Ogasawara K; Sonoda Y; Saito K; Nobusawa S; Nakazato Y; Kitanaka C; Kayama T; Tominaga T;
Neurol Med Chir (Tokyo); 2020 Nov; 60(11):543-552. PubMed ID: 33071274
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors.
Gallo P; Cecchi PC; Locatelli F; Rizzo P; Ghimenton C; Gerosa M; Pinna G
Br J Neurosurg; 2013 Dec; 27(6):759-64. PubMed ID: 23514331
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature.
Detti B; Scoccianti S; Maragna V; Lucidi S; Ganovelli M; Teriaca MA; Caini S; Desideri I; Agresti B; Greto D; Buccoliero AM; Puppa AD; Sardi I; Livi L
Radiol Med; 2022 Oct; 127(10):1134-1141. PubMed ID: 35951279
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features and Surgical Results of Pediatric Pleomorphic Xanthoastrocytoma: Analysis of 17 Cases with a Literature Review.
Wu W; Zuo P; Li C; Gong J
World Neurosurg; 2021 Jul; 151():e778-e785. PubMed ID: 33964500
[TBL] [Abstract][Full Text] [Related]
9. MR Imaging Features of Anaplastic Pleomorphic Xanthoastrocytoma Mimicking High-Grade Astrocytoma.
She D; Liu J; Xing Z; Zhang Y; Cao D; Zhang Z
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1446-1452. PubMed ID: 29903923
[TBL] [Abstract][Full Text] [Related]
10. Peritumoral Edema Affects the Prognosis in Adult Pleomorphic Xanthoastrocytoma: Retrospective Analysis of 25 Patients.
Byun J; Hong SH; Kim YH; Kim JH; Kim CJ
World Neurosurg; 2018 Jun; 114():e457-e467. PubMed ID: 29545226
[TBL] [Abstract][Full Text] [Related]
11. Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.
Perkins SM; Mitra N; Fei W; Shinohara ET
J Neurooncol; 2012 Oct; 110(1):99-104. PubMed ID: 22843450
[TBL] [Abstract][Full Text] [Related]
12. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas.
Reifenberger G; Kaulich K; Wiestler OD; Blümcke I
Acta Neuropathol; 2003 Apr; 105(4):358-64. PubMed ID: 12624789
[TBL] [Abstract][Full Text] [Related]
13. Cerebellar pleomorphic xanthoastrocytoma in the setting of neurofibromatosis type-I: Does it portend a different prognosis? A case report and systematic review.
Mathkour M; Banerjee S; Werner C; Hanna J; Abou-Al-Shaar H; Dindial R; Scullen T; Boehm L; Tubbs RS; Ware ML
Clin Neurol Neurosurg; 2021 Jan; 200():106346. PubMed ID: 33160715
[TBL] [Abstract][Full Text] [Related]
14. Clinical, Morphological, and Molecular Study on Grade 2 and 3 Pleomorphic Xanthoastrocytoma.
Zhang H; Ma XJ; Xiang XP; Wang QY; Tang JL; Yu XY; Xu JH
Curr Oncol; 2023 Feb; 30(2):2405-2416. PubMed ID: 36826144
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic alterations in pleomorphic xanthoastrocytoma.
Paulus W; Lisle DK; Tonn JC; Wolf HK; Roggendorf W; Reeves SA; Louis DN
Acta Neuropathol; 1996; 91(3):293-7. PubMed ID: 8834542
[TBL] [Abstract][Full Text] [Related]
16. BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study.
Ma C; Feng R; Chen H; Hameed NUF; Aibaidula A; Song Y; Wu J
World Neurosurg; 2018 Dec; 120():e1225-e1233. PubMed ID: 30240866
[TBL] [Abstract][Full Text] [Related]
17. An anaplastic pleomorphic xanthoastrocytoma with periventricular extension: An autopsy case report and review of the literature.
Matsumoto Y; Kobayashi M; Shingu K; Tateishi A; Ohya M; Sano K; Negishi T; Shigeto S; Kobayashi T; Hara Y; Kakizawa Y; Kanno H
Neuropathology; 2020 Oct; 40(5):507-514. PubMed ID: 32578272
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single Institute.
Korshunov A; Golanov A
J Neurooncol; 2001 Mar; 52(1):63-72. PubMed ID: 11451204
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
Kaulich K; Blaschke B; Nümann A; von Deimling A; Wiestler OD; Weber RG; Reifenberger G
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1092-9. PubMed ID: 12484572
[TBL] [Abstract][Full Text] [Related]
20. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.
Marton E; Feletti A; Orvieto E; Longatti P
J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
